These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 30974904)

  • 21. Gene and Induced Pluripotent Stem Cell Therapy for Retinal Diseases.
    Maeda A; Mandai M; Takahashi M
    Annu Rev Genomics Hum Genet; 2019 Aug; 20():201-216. PubMed ID: 31018110
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Emerging concepts in the treatment of optic neuritis: mesenchymal stem cell-derived extracellular vesicles.
    Aneesh A; Liu A; Moss HE; Feinstein D; Ravindran S; Mathew B; Roth S
    Stem Cell Res Ther; 2021 Dec; 12(1):594. PubMed ID: 34863294
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel stem cell and gene therapy in diabetic retinopathy, age related macular degeneration, and retinitis pigmentosa.
    Ludwig PE; Freeman SC; Janot AC
    Int J Retina Vitreous; 2019; 5():7. PubMed ID: 30805203
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetically-modified human mesenchymal stem cells to express erythropoietin enhances differentiation into retinal photoreceptors: An in-vitro study.
    Ding SLS; Koh AE; Kumar S; Ali Khan MS; Alzahrani B; Mok PL
    J Photochem Photobiol B; 2019 Jun; 195():33-38. PubMed ID: 31060031
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Self-assembling peptide modified with QHREDGS as a novel delivery system for mesenchymal stem cell transplantation after myocardial infarction.
    Cai H; Wu FY; Wang QL; Xu P; Mou FF; Shao SJ; Luo ZR; Zhu J; Xuan SS; Lu R; Guo HD
    FASEB J; 2019 Jul; 33(7):8306-8320. PubMed ID: 30970221
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atorvastatin: an efficient step forward in mesenchymal stem cell therapy of diabetic retinopathy.
    Mottaghi S; Larijani B; Sharifi AM
    Cytotherapy; 2013 Mar; 15(3):263-6. PubMed ID: 23253439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CRISPR-Based Genome Editing as a New Therapeutic Tool in Retinal Diseases.
    Rasoulinejad SA; Maroufi F
    Mol Biotechnol; 2021 Sep; 63(9):768-779. PubMed ID: 34057656
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multimodal Delivery of Isogenic Mesenchymal Stem Cells Yields Synergistic Protection from Retinal Degeneration and Vision Loss.
    Bakondi B; Girman S; Lu B; Wang S
    Stem Cells Transl Med; 2017 Feb; 6(2):444-457. PubMed ID: 28191768
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mesenchymal stem cells and potential applications in treating ocular disease.
    Joe AW; Gregory-Evans K
    Curr Eye Res; 2010 Nov; 35(11):941-52. PubMed ID: 20958182
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transplantation of BDNF-secreting mesenchymal stem cells provides neuroprotection in chronically hypertensive rat eyes.
    Harper MM; Grozdanic SD; Blits B; Kuehn MH; Zamzow D; Buss JE; Kardon RH; Sakaguchi DS
    Invest Ophthalmol Vis Sci; 2011 Jun; 52(7):4506-15. PubMed ID: 21498611
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhancers of mesenchymal stem cell stemness and therapeutic potency.
    Al-Azab M; Idiiatullina E; Safi M; Hezam K
    Biomed Pharmacother; 2023 Jun; 162():114356. PubMed ID: 37040673
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bioenergetic Crosstalk between Mesenchymal Stem Cells and various Ocular Cells through the intercellular trafficking of Mitochondria.
    Jiang D; Chen FX; Zhou H; Lu YY; Tan H; Yu SJ; Yuan J; Liu H; Meng W; Jin ZB
    Theranostics; 2020; 10(16):7260-7272. PubMed ID: 32641991
    [No Abstract]   [Full Text] [Related]  

  • 33. Intravenous Infusion of Umbilical Cord Mesenchymal Stem Cells Maintains and Partially Improves Visual Function in Patients with Advanced Retinitis Pigmentosa.
    Zhao T; Liang Q; Meng X; Duan P; Wang F; Li S; Liu Y; Yin ZQ
    Stem Cells Dev; 2020 Aug; 29(16):1029-1037. PubMed ID: 32679004
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stem Cell Therapy for Retinal Degeneration: The Evidence to Date.
    Sharma A; Jaganathan BG
    Biologics; 2021; 15():299-306. PubMed ID: 34349498
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potential therapeutic applications of mesenchymal stem cells for the treatment of eye diseases.
    Mannino G; Russo C; Longo A; Anfuso CD; Lupo G; Lo Furno D; Giuffrida R; Giurdanella G
    World J Stem Cells; 2021 Jun; 13(6):632-644. PubMed ID: 34249232
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mesenchymal stem cell-derived extracellular vesicles protect retina in a mouse model of retinitis pigmentosa by anti-inflammation through miR-146a-Nr4a3 axis.
    Zhang J; Li P; Zhao G; He S; Xu D; Jiang W; Peng Q; Li Z; Xie Z; Zhang H; Xu Y; Qi L
    Stem Cell Res Ther; 2022 Aug; 13(1):394. PubMed ID: 35922863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advances in the applications of mesenchymal stem cell-conditioned medium in ocular diseases.
    Zhang C; Xiao J; Fa L; Jiang F; Jiang H; Zhou L; Xu Z
    Exp Eye Res; 2023 Aug; 233():109560. PubMed ID: 37385531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Therapeutic Potential of Mesenchymal Stromal Cells in the Treatment of Chemotherapy-Induced Tissue Damage.
    Rühle A; Lopez Perez R; Zou B; Grosu AL; Huber PE; Nicolay NH
    Stem Cell Rev Rep; 2019 Jun; 15(3):356-373. PubMed ID: 30937640
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role and mechanism of mitochondrial functions and energy metabolism in the function regulation of the mesenchymal stem cells.
    Yan W; Diao S; Fan Z
    Stem Cell Res Ther; 2021 Feb; 12(1):140. PubMed ID: 33597020
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Applications of mesenchymal stem cells in ocular surface diseases: sources and routes of delivery.
    Soleimani M; Masoumi A; Momenaei B; Cheraqpour K; Koganti R; Chang AY; Ghassemi M; Djalilian AR
    Expert Opin Biol Ther; 2023; 23(6):509-525. PubMed ID: 36719365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.